- $134.17m
- $28.48m
- $33.03m
Brief: Maxcyte Buys Sequre Dx For $4.5 Million
MaxCyte, Inc. MaxCyte, Inc. - MXCR - MaxCyte® Acquires SeQure Dx
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
MaxCyte, Inc. MaxCyte, Inc. - MXCR - MaxCyte Announces Retirement of Board Member
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
Brief: Maxcyte Announces Streamlined Operations And Raises 2024 Revenue Guidance
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Holding(s) in Company
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Third Quarter 2024 Financial Results
MaxCyte Inc reports results for the quarter ended in September 30 - Earnings Summary